NLRC4 mutation | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

7,011 results for “NLRC4 mutation”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency

15 participants · First posted Apr 14, 2017

Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency As Open Label Extension

11 participants · First posted Apr 30, 2018

Study of Factors of Genetic Susceptibility Associated to Severe Caries Phenotype

390 participants · First posted Oct 8, 2007

Not yet recruiting

ASCiminib, With or Without Dasatinib Combination, as a 2nd-Line Therapy to ADVANCE the Treatment for Chronic Myelogenous Leukemia in Chronic Phase (ASC2ADVANCE)

45 participants · First posted Apr 20, 2026

Not yet recruiting

Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13)

650 participants · First posted Aug 13, 2025

Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)

3,200 participants · First posted Nov 28, 2016

C677T Methylenetetrahydrofolate Reductase Mutation

363 participants · First posted May 18, 2023

Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa

71 participants · First posted Jul 8, 2015

The Mutation Profile and Prognosis in AML With IDH1/2 Mutation

1,015 participants · First posted Jun 4, 2025

Active, not recruiting

Study to Evaluate the Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations

17 participants · First posted Nov 23, 2020

Page 1 of 549